Search

everythinglearnresearchcommunity

for

Search:↓

The combination therapy is effective and well-tolerated for treating esophageal cancer.

Baricitinib helps regrow hair in teens with severe alopecia areata.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

The rash resolved after stopping ponatinib.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Ritlecitinib is effective and safe for long-term treatment of alopecia areata.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

The model and estimator can predict drug exposure in kidney transplant patients well.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.